Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Gynecomastia Surgery & Its Aftermath

The most common cosmetic surgery for men on androgens

Evidence grade 4 of 5, Strong. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Surgical procedure

Reference only. Not medical advice.

What can go wrong

Surgical: hematoma, contour deformity ('crater'), scarring, altered or lost nipple sensation, asymmetry, need for revision. Recurrence if the hormonal driver continues.

This is something to take to a clinician. The Atlas can tell you what is known about gynecomastia surgery & its aftermath in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Gynecomastia (glandular male breast tissue) is a common consequence of the estrogen surge that follows aromatization of high-dose testosterone/AAS, of certain medications, and of pubertal or idiopathic causes. Once true glandular tissue has formed, it does not regress with aromatase inhibitors or SERMs, surgery (gland excision, often with liposuction) is the definitive treatment. It is among the most common cosmetic operations men seek, heavily marketed by cosmetic-surgery clinics. This entry documents the procedure, its risks (contour irregularity, scarring, altered nipple sensation, hematoma), and the importance of evaluating the hormonal cause first.

When the estrogen damage is done, surgery is the only fix.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Documents gynecomastia surgery and prevention

Safety in detail

Gynecomastia surgery is an elective operation with real risks (contour deformity, scarring, nipple sensation change). Underlying hormonal causes should be evaluated first.

What people get wrong

  • Often saidAromatase inhibitors can reverse gyno

    ActuallyAIs and SERMs may help early/glandular-development phases, but once mature glandular tissue forms it does not regress, surgery is the only definitive treatment.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Cause (AAS context)
Aromatization of high-dose androgens to estrogen
Key point
Established glandular tissue is surgery-only
Procedure
Gland excision +/- liposuction

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Gynecomastia Surgery & Its Aftermath. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • Where we land. We have not taken a position on this yet.

Sources

No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.